Data from ImmunoGenesis’ Lead Programs Presented in Six Posters at Society for Immunotherapy of Cancer (SITC) Conference
News
Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Wellsheet Collaborates with Horizon to Provide Clinicians with a Single View of Key Data and Insights within their EHR Workflow
New Jersey Health Providers Can Access a Near Real-Time Comprehensive View of Patients’ Medical History
Venatorx Pharmaceuticals Announces Collaboration with Roche to Develop New Class of Antibiotics targeting WHO Critical Priority Pathogen
Development of novel antibiotics to circumvent antimicrobial resistance and address increasing threat of superbugs
Phrase Health Announces $3M Investment from Health IT Leaders: LionBird, Vizient, Inc., and BioAdvance
The new investment will enhance growth initiatives, accelerate development, and support additional research to enhance platform capabilities.
Immunome Presents Compelling Preclinical Data on Anti-IL-38 Antibody Program at the American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Annovis Bio Announces Positive Phase Two Efficacy Data for Treatment of Parkinson’s Disease
Data Shows Statistically Significant Improvements in Speed and Motor Function in PD Patients
Annovis Bio to Request Meeting with FDA on Next Steps in Clinical Development
Investor Conference Call to be Hosted Tuesday, October 5th, 2021, at 9:00 am ET
Renovacor Announces the Appointment of Kumar Dhanasekharan, Ph.D., as Senior Vice President of Technical Operations
Dr. Dhanasekharan joins Renovacor with extensive experience overseeing development, manufacturing and supply operations for biologics including AAV gene therapies
Halo Labs Launches the Aura GT™ for Gene Therapy Product Quality
Aura GT is the first system specifically designed to quantify capsid aggregates and identify the mechanism of aggregation